/
partner with:

Health & Physiology

showing 76-80 of 151 breaks
Understanding how COVID-19 Patients shed viral particles into their environment

The University of Nebraska Medical Center and Nebraska Medicine were among the first U.S. hospitals to provide care for individuals infected with the SARS-CoV-2 virus. When the first news of viral pneumonia in Wuhan, China began appearing in December of 2019, the nursing and research... click to read more

  • Joshua L. Santarpia | Associate Professor at Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA
    •
COVID-19
SARS-CoV-2
environmental contamination
Views 4158
Reading time 3.5 min
published on Jan 4, 2021
Mosquito travel diaries: destinations, routes, stowaways, and … cost

Although grappling with a viral pandemic, half the world's population is at risk of illness or death from malaria, dengue, and other mosquito-borne diseases. Therefore, it's no surprise that controlling mosquitoes is a top global health priority. But there's a lot we don't know about... click to read more

  • Tovi Lehmann | Research Fellow at Laboratory of Malaria and Vector Research, NIAID, NIH, Rockville, MD, USA
    •
  • Ben J. Krajacich | Research Fellow at Laboratory of Malaria and Vector Research, NIAID, NIH, Rockville, MD, USA
    •
  • Roy Faiman | Research Fellow at Laboratory of Malaria and Vector Research, NIAID, NIH, Rockville, MD, USA
    •
Africa
disease surveillance
Windborne insect migration
pathogen spread
One Health
Views 3898
Reading time 4 min
published on Dec 10, 2020
Charting the immune landscape in brain cancers

Thanks to revolutionary advances in cancer research, several cancer types can today be treated and controlled over long periods, similar to other chronic diseases. Among the most recent developments are immunotherapies, which aim to activate the patients' immune system to fight cancer. While immunotherapies have... click to read more

  • Klara Soukup | Research Associate at Ludwig Institute for Cancer Research, Department of Oncology, University of Lausanne, Lausanne, Switzerland
    •
  • Johanna A. Joyce | Professor at Ludwig Institute for Cancer Research, Department of Oncology, University of Lausanne, Lausanne, Switzerland
    •
immune cells
immunology
brain cancer
tumor microenvironment
Views 6179
Reading time 4 min
published on Nov 27, 2020
Neutralizing antibodies: the Elite Squad to combat SARS-CoV-2 infection

The rapid global transmission of SARS-CoV-2 poses a severe health emergency affecting over 20 million people worldwide as of 12 August. The research communities have taken immediate and enormous actions in search of therapeutic and prophylactic interventions. The major strategies undertaken include repurposing "old" drugs,... click to read more

  • Guanqiao Li | Research Associate at Center for Global Health and Infectious Diseases, School of Medicine and Vanke School of Public Health, Tsinghua University, Beijing, China
    •
  • Yang Liu | Research Associate at Center for Global Health and Infectious Diseases, School of Medicine and Vanke School of Public Health, Tsinghua University, Beijing, China
    •
  • Linqi Zhang | Professor at Center for Global Health and Infectious Diseases, School of Medicine and Vanke School of Public Health, Tsinghua University, Beijing, China
    •
SARS-CoV-2
neutralizing antibodies
receptor-binding domain (RBD)
Views 3536
Reading time 2.5 min
published on Nov 20, 2020
T cells: an essential but neglected component against COVID-19

The current COVID-19 pandemic has brought into our daily conversations scientific topics previously only discussed among scientists in academic environments. When the media inform us about the rise or fall of new cases of SARS-CoV-2 infection in the world, questions about immunity and protection follow... click to read more

  • Antonio Bertoletti | Professor at Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
    •
  • Anthony Tan | Senior Research Fellow at Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
    •
  • Nina Le Bert | Research Fellow at Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
    •
CoV-19
SARS-CoV-2
T cells
antiviral immunity
Views 4246
Reading time 4.5 min
published on Nov 4, 2020